Literature DB >> 15519886

The role of the AT1 angiotensin receptor in cardiac hypertrophy: angiotensin II receptor or stretch sensor?

László Hunyady1, Gábor Turu.   

Abstract

Activation of the AT(1) angiotensin receptor is a clinically important maladaptive response during cardiac hypertrophy. Autocrine and paracrine effects of locally generated angiotensin II, are believed to be the main mediators of these responses. However, a recent report has suggested that mechanical stress can activate AT(1) receptors independently of angiotensin II generation. This finding, as well as recent studies on intracrine effects and the pharmacological consequences of receptor hetero-oligomerization, suggest that unexpected mechanisms could contribute to the role of the renin-angiotensin system during cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519886     DOI: 10.1016/j.tem.2004.09.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  8 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy.

Authors:  Meng Du; Kun Huang; Lu Gao; Liu Yang; Wen-Shuo Wang; Bo Wang; Kai Huang; Dan Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

3.  TRPC3 participates in angiotensin II type 1 receptor-dependent stress-induced slow increase in intracellular Ca2+ concentration in mouse cardiomyocytes.

Authors:  Yohei Yamaguchi; Gentaro Iribe; Toshiyuki Kaneko; Ken Takahashi; Takuro Numaga-Tomita; Motohiro Nishida; Lutz Birnbaumer; Keiji Naruse
Journal:  J Physiol Sci       Date:  2017-01-19       Impact factor: 2.781

4.  Vasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A.

Authors:  Y Li; Y Saito; K Kuwahara; X Rong; I Kishimoto; M Harada; M Horiuchi; M Murray; K Nakao
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

Review 5.  Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders.

Authors:  Thomas Walther; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

6.  An Updated Review on the Phytochemistry, Pharmacology, and Clinical Trials of Salacia oblonga.

Authors:  Priya Singh Kushwaha; Ashok K Singh; Amit K Keshari; Siddhartha Maity; Sudipta Saha
Journal:  Pharmacogn Rev       Date:  2016 Jul-Dec

Review 7.  The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experiments.

Authors:  Min Li; Xue Xu; Xinyu Yang; Joey S W Kwong; Hongcai Shang
Journal:  BMC Complement Altern Med       Date:  2017-08-10       Impact factor: 3.659

Review 8.  The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor.

Authors:  Gábor Turu; András Balla; László Hunyady
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.